Brand Logo
Brand Logo
Brand Logo

Your Specialist CDMO

A boutique CDMO partner for breakthrough wound care and tissue regeneration devices.

About Us

Location

Milton Park, Oxfordshire

We're based on the prestigious Milton Park science estate, just south of Oxford, UK. Here, we have offices, formulation/characterisation labs, a warehouse and a prototyping facility.


We're based on the prestigious Milton Park science estate, just south of Oxford, UK. Here, we have offices, formulation/characterisation labs, a warehouse and a prototyping facility.


a black and white photo of a person's hands
Milton Park, Oxfordshire

We're based on the prestigious Milton Park science estate, just south of Oxford, UK. Here, we have offices, formulation/characterisation labs, a warehouse and a prototyping facility.


We're based on the prestigious Milton Park science estate, just south of Oxford, UK. Here, we have offices, formulation/characterisation labs, a warehouse and a prototyping facility.


a black and white photo of a person's hands
Milton Park, Oxfordshire

We're based on the prestigious Milton Park science estate, just south of Oxford, UK. Here, we have offices, formulation/characterisation labs, a warehouse and a prototyping facility.


We're based on the prestigious Milton Park science estate, just south of Oxford, UK. Here, we have offices, formulation/characterisation labs, a warehouse and a prototyping facility.


a black and white photo of a person's hands

Team

Phil Andrews, CEO

30 years at the intersection of innovation and commercialisation in medical devices. Expertise in product design, IP generation (nine patent families) and B2B commercialisation. Two successful exits, numerous $ multi-million collaborations, successful university spin-out (ScubaTx) and a successful turn-around.

30 years at the intersection of innovation and commercialisation in medical devices. Expertise in product design, IP generation (nine patent families) and B2B commercialisation. Two successful exits, numerous $ multi-million collaborations, successful university spin-out (ScubaTx) and a successful turn-around.

person writing on white paper
Phil Andrews, CEO

30 years at the intersection of innovation and commercialisation in medical devices. Expertise in product design, IP generation (nine patent families) and B2B commercialisation. Two successful exits, numerous $ multi-million collaborations, successful university spin-out (ScubaTx) and a successful turn-around.

30 years at the intersection of innovation and commercialisation in medical devices. Expertise in product design, IP generation (nine patent families) and B2B commercialisation. Two successful exits, numerous $ multi-million collaborations, successful university spin-out (ScubaTx) and a successful turn-around.

person writing on white paper

Team

Dr Mo Alkattan, CSO

17+ years leading polymer and hydrogel-based medical technology programmes across Class I–III devices, implantables, and drug-device combinations. Delivered products to EU, UK, US, and global markets. Deep expertise spanning EU MDR, FDA, UKCA regulatory strategy, ISO 14971 risk management, ISO 10993 biocompatibility, design history files, GMP scale-up, and commercialisation.

17+ years leading polymer and hydrogel-based medical technology programmes across Class I–III devices, implantables, and drug-device combinations. Delivered products to EU, UK, US, and global markets. Deep expertise spanning EU MDR, FDA, UKCA regulatory strategy, ISO 14971 risk management, ISO 10993 biocompatibility, design history files, GMP scale-up, and commercialisation.

Dr Mo Alkattan, CSO

17+ years leading polymer and hydrogel-based medical technology programmes across Class I–III devices, implantables, and drug-device combinations. Delivered products to EU, UK, US, and global markets. Deep expertise spanning EU MDR, FDA, UKCA regulatory strategy, ISO 14971 risk management, ISO 10993 biocompatibility, design history files, GMP scale-up, and commercialisation.

17+ years leading polymer and hydrogel-based medical technology programmes across Class I–III devices, implantables, and drug-device combinations. Delivered products to EU, UK, US, and global markets. Deep expertise spanning EU MDR, FDA, UKCA regulatory strategy, ISO 14971 risk management, ISO 10993 biocompatibility, design history files, GMP scale-up, and commercialisation.

Dr Mo Alkattan, CSO

17+ years leading polymer and hydrogel-based medical technology programmes across Class I–III devices, implantables, and drug-device combinations. Delivered products to EU, UK, US, and global markets. Deep expertise spanning EU MDR, FDA, UKCA regulatory strategy, ISO 14971 risk management, ISO 10993 biocompatibility, design history files, GMP scale-up, and commercialisation.

17+ years leading polymer and hydrogel-based medical technology programmes across Class I–III devices, implantables, and drug-device combinations. Delivered products to EU, UK, US, and global markets. Deep expertise spanning EU MDR, FDA, UKCA regulatory strategy, ISO 14971 risk management, ISO 10993 biocompatibility, design history files, GMP scale-up, and commercialisation.

Vision

What Drives Us

The world doesn't need more me-too wound dressings and medical devices. We're here to collaborate with businesses that are looking to bring better, differentiated and protected products to the market.

The world doesn't need more me-too wound dressings and medical devices. We're here to collaborate with businesses that are looking to bring better, differentiated and protected products to the market.

What Drives Us

The world doesn't need more me-too wound dressings and medical devices. We're here to collaborate with businesses that are looking to bring better, differentiated and protected products to the market.

The world doesn't need more me-too wound dressings and medical devices. We're here to collaborate with businesses that are looking to bring better, differentiated and protected products to the market.

Expertise

Wound Care Expertise

We have particular expertise designing products for the various wound care markets. From OTC through to skin closure, pressure injury prevention, chest seals, chronic wound care, vascular access, and wound scaffold technologies..

We have particular expertise designing products for the various wound care markets. From OTC through to skin closure, pressure injury prevention, chest seals, chronic wound care, vascular access, and wound scaffold technologies..

people sitting on chair inside building
Wound Care Expertise

We have particular expertise designing products for the various wound care markets. From OTC through to skin closure, pressure injury prevention, chest seals, chronic wound care, vascular access, and wound scaffold technologies..

We have particular expertise designing products for the various wound care markets. From OTC through to skin closure, pressure injury prevention, chest seals, chronic wound care, vascular access, and wound scaffold technologies..

people sitting on chair inside building

Let's

Collaborate

Get in touch

Do you prefer email?

team@gelativity.com

Copy Icon
Copied Icon

Copied

Let's

Collaborate

Get in touch

Do you prefer email?

team@gelativity.com

Copy Icon
Copied Icon

Copied

Avatar
Phil Andrews

Co-Founder

Let's

Collaborate

Get in touch

Do you prefer email?

team@gelativity.com

Copy Icon
Copied Icon

Copied